A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.

Guzmán, M

A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. [electronic resource] - British journal of cancer Jul 2006 - 197-203 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

0007-0920

10.1038/sj.bjc.6603236 doi


Adult
Aged
Biopsy
Brain Neoplasms--drug therapy
Cannabinoid Receptor Antagonists
Cell Proliferation--drug effects
Disease Progression
Dronabinol--adverse effects
Female
Glioblastoma--drug therapy
Humans
Male
Middle Aged
Neoplasm Recurrence, Local
Pilot Projects
Receptors, Cannabinoid--biosynthesis
Safety
Survival Rate
Treatment Outcome
Tumor Cells, Cultured